Scholarlink

Background <p>Oral Lichen Planus (OLP) is a chronic inflammatory disorder that may progress to Oral Squamous Cell Carcinoma (OSCC). Lipid metabolism dysregulation has been implicated in tumor development and immune response modulation. This study aims to explore the role of lipid metabolism, particularly the lipids diacylglycerol (DAG), triacylglycerol (TAG), and phosphatidylcholine (PC), in the progression from OLP to OSCC, and to identify potential therapeutic targets for prevention and treatment.</p> Methods <p>We performed a Mendelian randomization (MR) analysis to investigate the causal relationships between lipid metabolism and the risk of OLP and OSCC. Differential gene expression analysis was conducted to identify key genes related to lipid metabolism. The interactions of lipid species and key genes were examined using drug databases (DrugBank, DGIdb, and TCMSP) to explore potential drug candidates. Enrichment analysis of signaling pathways, including PPAR signaling, was also conducted to understand the underlying mechanisms.</p> Results <p>Our MR analysis revealed that DAG exerts a protective effect in OLP (OR &lt; 1), but its role shifts to a risk factor in OSCC (OR &gt; 1), potentially by altering the tumor immune microenvironment. TAG and PI dysregulation also plays a critical role in tumorigenesis. Gene expression analysis identified several key lipid metabolism-related genes, including SLC27A6, FABP3, FABP4, ADIPOQ, and PLIN1, whose expression differed between OLP and OSCC, highlighting their importance in tumor progression. These genes were enriched in the PPAR signaling pathway, suggesting its involvement in tumor growth and immune modulation. Potential drug candidates, such as palm acid (PA), Imatinib, and Curcumin, were identified through drug-repurposing strategies.</p> Conclusion <p>Lipid metabolism dysregulation plays a crucial role in the progression of OLP to OSCC. Targeting key lipid metabolism pathways and genes, such as DAG, TAG, PI, and the PPAR pathway, may offer promising strategies for early diagnosis and therapeutic intervention. This study provides novel insights into the molecular mechanisms of OLP-to-OSCC progression and suggests potential drug candidates, including natural compounds, for future clinical applications. Further research is needed to validate these findings in clinical settings.</p> Clinical trial number <p>Not applicable.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Elucidating the role of lipid metabolism dysregulation in the transition from oral lichen planus to oral squamous cell carcinoma

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年4月16日

查看全文
  • Manman Yao,
  • Yueting Lu,
  • Tiejun Liu,
  • Hualin Lu,
  • Hongyue Shang,
  • Bo Dong,
  • Ji-ao Zhang

摘要

Background

Oral Lichen Planus (OLP) is a chronic inflammatory disorder that may progress to Oral Squamous Cell Carcinoma (OSCC). Lipid metabolism dysregulation has been implicated in tumor development and immune response modulation. This study aims to explore the role of lipid metabolism, particularly the lipids diacylglycerol (DAG), triacylglycerol (TAG), and phosphatidylcholine (PC), in the progression from OLP to OSCC, and to identify potential therapeutic targets for prevention and treatment.

Methods

We performed a Mendelian randomization (MR) analysis to investigate the causal relationships between lipid metabolism and the risk of OLP and OSCC. Differential gene expression analysis was conducted to identify key genes related to lipid metabolism. The interactions of lipid species and key genes were examined using drug databases (DrugBank, DGIdb, and TCMSP) to explore potential drug candidates. Enrichment analysis of signaling pathways, including PPAR signaling, was also conducted to understand the underlying mechanisms.

Results

Our MR analysis revealed that DAG exerts a protective effect in OLP (OR < 1), but its role shifts to a risk factor in OSCC (OR > 1), potentially by altering the tumor immune microenvironment. TAG and PI dysregulation also plays a critical role in tumorigenesis. Gene expression analysis identified several key lipid metabolism-related genes, including SLC27A6, FABP3, FABP4, ADIPOQ, and PLIN1, whose expression differed between OLP and OSCC, highlighting their importance in tumor progression. These genes were enriched in the PPAR signaling pathway, suggesting its involvement in tumor growth and immune modulation. Potential drug candidates, such as palm acid (PA), Imatinib, and Curcumin, were identified through drug-repurposing strategies.

Conclusion

Lipid metabolism dysregulation plays a crucial role in the progression of OLP to OSCC. Targeting key lipid metabolism pathways and genes, such as DAG, TAG, PI, and the PPAR pathway, may offer promising strategies for early diagnosis and therapeutic intervention. This study provides novel insights into the molecular mechanisms of OLP-to-OSCC progression and suggests potential drug candidates, including natural compounds, for future clinical applications. Further research is needed to validate these findings in clinical settings.

Clinical trial number

Not applicable.